BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 5, 2017
View Archived Issues
Aptevo Therapeutics to sell hyperimmune commercial products to Saol Therapeutics
Read More
Fresenius Kabi closes acquisition of Merck KGaA's biosimilars business
Read More
Takeda and Noile-Immune Biotech enter a collaboration to advance next generation CAR-T cell therapy
Read More
GlaxoSmithKline, ViiV identify new HIV allosteric integrase inhibitors
Read More
ReViral begins dosing in phase IIa study of RV-521 for RSV
Read More
Promising RORgammaT inhibitors discovered at Merck & Co.
Read More
FDA places clinical hold on phase I studies of UCART-123
Read More
Increased SIRT4 expression linked to accelerated heart failure development
Read More
Novartis reports promising data from phase III study of fingolimod in pediatric MS
Read More
Enrollment completed in phase IIb study of BGS-649 for hypogonadotropic hypogonadism
Read More
PMV Pharmaceuticals describes novel compounds restoring mutant p53 function
Read More
Concert Pharmaceuticals presents new PPARalpha, PPARdelta agonists
Read More
Vanderbilt University divulges novel muscarinic acetylcholine M1 receptor modulators
Read More
Novel bile acid receptor agonists discovered at Alios BioPharma
Read More
Golden Biotechnology presents new compounds for liver cancer
Read More
First-in-human phase I results for (Z)-endoxifen in endocrine-refractory metastatic breast cancer
Read More
Axxam and Sanofi begin neurodegeneration research collaboration
Read More
Funding pledged to Global Antibiotic Research and Development Partnership
Read More
New phase I/II study investigates H3B-6545 in advanced ER-positive, HER2-negative breast cancer
Read More